[Fibrinolytic treatment of deep vein thrombosis and lung embolism].
Selective evaluation prior to determining the indication for thrombolytic therapy is just as important for therapeutic success as choosing the appropriate fibrinolytic agent. During this initial stage, the localization, age, extension, and possible consequences of the thrombosis must be determined with suitable as well as specific methods. Selection of the fibrinolytic agent and careful monitoring of the thrombolysis should ensure a maximum therapeutic effect with a minimum of bleeding complications.
D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008991:Monitoring, Physiologic; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000175:diagnosis / Q000188:drug therapy*
D005343:Fibrinolytic Agents
Fibrinolytische Behandlung von tiefen Venenthrombosen und Lungenembolien.